Grace licenses Formac’s bioavailability enhancement tech
18. October 2017
WR Grace & Co has licensed rights to a bioavailability enhancement technology from Formac Pharmaceuticals NV.
Excipients and Drug Delivery
Syloid® silica excipients are the intelligent choice for many pharmaceutical applications due their unique morphology.
The combined adsorption capacity, porosity, particle size, and greater internal surface area allow it to provide several benefits simultaneously that can help minimize the number of excipients required, expedite manufacturing, and improve efficacy of the final dosage form.